ABY-035 in the Treatment of Subjects With Ankylosing Spondylitis
Public ClinicalTrials.gov record NCT04795141. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety and Tolerability of ABY-035 in the Treatment of Subjects With Ankylosing Spondylitis
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
ABY-035-204 is a clinical study to assess the efficacy of IL-17 blocker ABY-035 in ankylosing spondylitis(AS). The primary objective is to estimate the relationship between different dose regimens of ABY-035 and clinical response as assessed by Assessment of Spondyloarthritis International Society 40 (ASAS40) response at Week 16 in subjects with active AS.
Study identification
- NCT ID
- NCT04795141
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 25 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 24, 2021 (Actual)
- Primary completion
- Jul 11, 2022 (Actual)
- Completion
- Aug 30, 2022 (Actual)
- Last update posted
- Jul 12, 2023
2021 – 2022
United States locations
- U.S. sites
- 15
- U.S. states
- 10
- U.S. cities
- 15
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Arizona Arthritis & Rheumatology Research, PLLC | Glendale | Arizona | 85306 | — |
| Hope Clinical Research | Canoga Park | California | 91303 | — |
| Newport Huntington Medical Group | Huntington Beach | California | 92648 | — |
| Desert Medical Advances | Palm Desert | California | 92260 | — |
| Arthritis and Rheumatic Disease Specialties | Aventura | Florida | 33180 | — |
| Drucker Sarasota Arthritis Research Center | Sarasota | Florida | 34293 | — |
| Greater Chicago Specialty Physicians/ Clinical Investigation Specialists, Inc. | Schaumburg | Illinois | 60195 | — |
| Clinic of Robert Hozman, MD / Clinical Investigation Specialists, | Skokie | Illinois | 60076 | — |
| Klein & Associates, M.D., P.A. | Hagerstown | Maryland | 21740 | — |
| The Center for Rheumatology and Bone Research | Wheaton | Maryland | 20902 | — |
| M3 Emerging Medical Research, LLC | Durham | North Carolina | 27704 | — |
| Clinical Research Source, Inc. | Perrysburg | Ohio | 43551 | — |
| Altoona Center for Clinical Research | Duncansville | Pennsylvania | 16635 | — |
| HRMD Research | Dallas | Texas | 75240 | — |
| Seattle Rheumatology Associates | Seattle | Washington | 98122 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 32 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04795141, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 12, 2023 · Synced Oct 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT04795141 live on ClinicalTrials.gov.